Nuvectis Pharma Inc (NVCT)

10:14 AM

Why Nuvectis Pharma Inc. stock is on top investor watchlistsSkyrocketing investment returns - jammulinksnews.com

10:14 AM

06:19 AM

Nuvectis Pharma Inc. Stock Analysis and ForecastSuperior returns - Autocar Professional

06:19 AM

05:06 AM

What drives Nuvectis Pharma Inc. stock priceRecord-breaking capital gains - Autocar Professional

05:06 AM

Jul 24, 2025

What analysts say about Nuvectis Pharma Inc. stockUnstoppable profit momentum - PrintWeekIndia

Jul 24, 2025

Jul 22, 2025

Is Nuvectis Pharma Inc. a good long term investmentTremendous wealth creation - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

(NVCT) On The My Stocks Page - news.stocktradersdaily.com

Jul 22, 2025

Jul 21, 2025

Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights - sg.finance.yahoo.com

Jul 21, 2025

Jul 15, 2025

How Nuvectis Pharma Inc. stock performs during market volatilityFree Growth Investment Group - Newser

Jul 15, 2025

Jul 15, 2025

What makes Nuvectis Pharma Inc. stock price move sharplyHigh Confidence Trade Setups - Newser

Jul 15, 2025

Jul 15, 2025

Why Nuvectis Pharma Inc. stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser

Jul 15, 2025

Jul 12, 2025

When (NVCT) Moves Investors should Listen - news.stocktradersdaily.com

Jul 12, 2025

Jul 08, 2025

Nuvectis reports positive drug interaction study for cancer drug NXP900 By Investing.com - Investing.com Nigeria

Jul 08, 2025

Jul 08, 2025

Nuvectis Pharma, Inc. Announces Successful Completion of A Drug-Drug Interaction Study in Healthy Volunteers - MarketScreener

Jul 08, 2025

Jul 08, 2025

Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading Therapies - GlobeNewswire

Jul 08, 2025

Jul 02, 2025

Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Purchased by Oppenheimer & Co. Inc. - Defense World

Jul 02, 2025

Jul 01, 2025

(NVCT) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jul 01, 2025

Jun 30, 2025

Nuvectis Pharma, Inc.(NasdaqCM: NVCT) added to Russell 3000 Index - MarketScreener

Jun 30, 2025

Jun 29, 2025

Nuvectis Pharma (NASDAQ:NVCT) Lowered to “Sell” Rating by Wall Street Zen - Defense World

Jun 29, 2025

Jun 25, 2025

Is Nuvectis Pharma, Inc. technically bullish or bearish? - MarketsMojo

Jun 25, 2025

Jun 21, 2025

(NVCT) Proactive Strategies - news.stocktradersdaily.com

Jun 21, 2025

Jun 20, 2025

Silicon Valley - FinancialContent

Jun 20, 2025

Jun 18, 2025

Nuvectis Pharma: Still Interesting, But Still Too Risky To Jump In - Seeking Alpha

Jun 18, 2025

Jun 18, 2025

Insiders of Nuvectis Pharma, Inc. (NASDAQ:NVCT) must be disappointed as stock fell 10% after recent purchases - Yahoo Finance

Jun 18, 2025

Jun 18, 2025

Insider Stock Buying Of Nuvectis Pharma Delivers Return On US$2.19m Investment - simplywall.st

Jun 18, 2025

Jun 13, 2025

Nuvectis Pharma Approves Proposals at Annual Meeting - TipRanks

Jun 13, 2025